Brand Name
Kevzara
Generic Name
Sarilumab
View Brand Information FDA approval date: May 22, 2017
Classification: Interleukin-6 Receptor Antagonist
Form: Injection
What is Kevzara (Sarilumab)?
KEVZARA ® is an interleukin-6 receptor antagonist indicated for treatment of: adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to one or more disease-modifying antirheumatic drugs .
Approved To Treat
Top Global Experts
There are no experts for this drug
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment
Related Latest Advances
There is no latest advances for this treatment